Spruce Biosciences to present MPS IIIB natural history data at Child Neurology Society meeting
SPRB•Spruce Biosciences said it will present findings from Study 250-902 on severe pediatric MPS IIIB at the Child Neurology Society annual meeting on Oct. 15, 2026.
1. Study findings scheduled
The analyses track changes over time in cognition, motor function, communication and adaptive skills in the studied population. The data aim to sharpen disease-progression benchmarks that can guide clinical development strategy in MPS IIIB.
